Evidence map›Paper›PMID 33746944›Full record

ArticleFrontiers in immunology2021

Multi 'Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway.

Adam J Berlinberg, Emilie H Regner, Andrew Stahly, Ana Brar, Julie A Reisz, Mark E Gerich, Blair P Fennimore, Frank I Scott, Alison E Freeman, Kristine A Kuhn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Microbiology spectrum · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Adam J BerlinbergDivision of Rheumatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Emilie H RegnerDivision of Gastroenterology and Hepatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Andrew StahlyDivision of Rheumatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Ana BrarDepartment of Medicine, University of Colorado, Aurora, CO, United States.
Julie A ReiszDepartment of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO, United States.
Mark E GerichDivision of Gastroenterology and Hepatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Blair P FennimoreDivision of Gastroenterology and Hepatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Frank I ScottDivision of Gastroenterology and Hepatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Alison E FreemanDivision of Gastroenterology and Hepatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
Kristine A KuhnDivision of Rheumatology, Department of Medicine, University of Colorado, Aurora, CO, United States.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

Gene Regulation as a Foundation for Autoimmune Disease PreventionU01AI130830 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI WEIRAUCH, MATTHEW TYSON · 2017 to 2021
$7.2M
Research Training in Rheumatology INCLUDE Down Syndrome SupplementT32AR007534 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 1986 to 2026
$6.1M
The role of bacteria-produced indole in the development of autoimmune arthritisR01AR075033 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 2019 to 2026
$3.1M
Development of colonic intraepithelial lymphocytes and their role in epithelial and immune functionK08DK107905 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI KUHN, KRISTINE A. · 2016 to 2020
$716k
NIAID NIH HHS U01 AI130830NIAMS NIH HHS R01 AR075033NIAMS NIH HHS T32 AR007534NIDDK NIH HHS K08 DK107905
6 · The paper itself

Abstract

Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn's disease (CD, N=27), and Crohn's-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA.

Indexed as

Gastrointestinal MicrobiomeIntestinesMetabolomicsMetagenomicsCase-Control StudiesComputational BiologyDisease SusceptibilityDysbiosisGene Expression ProfilingGene Expression Regulation, BacterialHumansMetabolic Networks and PathwaysSpondylitis, AnkylosingTryptophanTryptophanankylosing spondylitisindolemetabolomicsmetagenomicsmicrobiomespondyloarthritistryptophan

Identifiers

PMID33746944
PMCPMC7966505
OpenAlexW3134526247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.